You are here

  • Home
  • Archive
  • Volume 81, Issue Suppl 1
  • OP0268 COMPARISON OF MAJOR CARDIOVASCULAR AND THROMBOEMBOLIC EVENTS IN SAFETY REPORTS BETWEEN RHEUMATOID ARTHRITIS PATIENTS TREATED WITH JAK INHIBITORS VERSUS ANTI-TNF: RESULTS FROM VigiBase

Article info

Article menu

Download PDFPDF

Scientific Abstracts
Oral Presentations
RA treatment: modern strategies and new molecules
OP0268 COMPARISON OF MAJOR CARDIOVASCULAR AND THROMBOEMBOLIC EVENTS IN SAFETY REPORTS BETWEEN RHEUMATOID ARTHRITIS PATIENTS TREATED WITH JAK INHIBITORS VERSUS ANTI-TNF: RESULTS FROM VigiBase
Free

Authors

  • F. Montastruc Toulouse University Hospital, Department of Medical and Clinical Pharmacology, Centre of PharmacoVigilance and Pharmacoepidemiology, Centre d’Investigation Clinique 1436, Team PEPSS « Pharmacologie En Population cohorteS et biobanqueS », Toulouse, France PubMed articlesGoogle scholar articles
  • C. Flumian Toulouse University Hospital, Department of Medical and Clinical Pharmacology, Centre of PharmacoVigilance and Pharmacoepidemiology, Toulouse, France PubMed articlesGoogle scholar articles
  • Y. Degboe Toulouse University Hospital, Rheumatology Center, Inserm UMR Infinity, Paul Sabatier University, Toulouse, France PubMed articlesGoogle scholar articles
  • A. Constantin Toulouse University Hospital, Rheumatology Center, Inserm UMR Infinity, Paul Sabatier University, Toulouse, France PubMed articlesGoogle scholar articles
  • A. Ruyssen-Witrand Toulouse University Hospital, Rheumatology Department, Centre d’Investigation Clinique 1436, Team PEPSS « Pharmacologie En Population cohorteS et biobanqueS », Toulouse University Hospital, Toulouse, France PubMed articlesGoogle scholar articles

Citation

Montastruc F, Flumian C, Degboe Y, et al
OP0268 COMPARISON OF MAJOR CARDIOVASCULAR AND THROMBOEMBOLIC EVENTS IN SAFETY REPORTS BETWEEN RHEUMATOID ARTHRITIS PATIENTS TREATED WITH JAK INHIBITORS VERSUS ANTI-TNF: RESULTS FROM VigiBase
Annals of the Rheumatic Diseases 2022;81:178-179.

Publication history

  • First published May 23, 2022.
Online issue publication 
May 23, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.